Group 1 - The core viewpoint of the article highlights that Guoen Technology (02768) has transferred shares from Morgan Stanley Hong Kong Securities to Huatai Hong Kong, with a market value of HKD 68.6328 million, accounting for 5.53% of the total shares [1] - Guoen Technology officially listed on the Hong Kong Stock Exchange on February 4, and was included in the Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving the chemical and health industries through research, production, and sales of industrial and commercial products [1] Group 2 - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, with a market share of 2.5% projected for 2024 [1]

Group 1 - The core viewpoint of the article highlights that Guo'en Technology (02768) has transferred shares from Morgan Stanley Hong Kong Securities to Huatai Hong Kong, with a market value of HKD 68.6328 million, representing 5.53% of the total shares [1] - Guo'en Technology officially listed on the Hong Kong Stock Exchange on February 4 and was included in the Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] Group 2 - According to Frost & Sullivan, Guo'en Technology is the second-largest organic polymer modified materials and organic polymer composite materials enterprise in China by sales revenue, with a market share of 2.5% projected for 2024 [1]

Group 1 - On February 4, Guoen Technology officially listed on the Hong Kong Stock Exchange, becoming the first company in Shandong Province to achieve A+H share dual listing in 2026 and the eighth H-share listed company in Qingdao [1] - On its first trading day, Guoen Technology's stock surged by 37.06%, reaching a market capitalization of HKD 14.864 billion, indicating strong market performance [1] - The company specializes in chemical new materials and health sectors, focusing on upstream and downstream products such as gelatin and collagen [1] Group 2 - The H-share issuance involved 30 million shares, raising approximately HKD 1 billion, which will be used for expanding production capacity in Thailand and domestically, establishing regional headquarters, and upgrading existing production bases [1] - The IPO received significant market recognition, with the public offering being oversubscribed by 2,251.85 times and the international placement by 10.03 times, making it one of the most highly subscribed new stocks recently [1] - Guoen Technology's successful listing contributes to the growth of the Qingdao Stock Exchange, which now has 21 listed companies and has raised over RMB 13 billion in IPO funds [2]

Group 1 - The core viewpoint of the article highlights that Guoen Technology (02768) experienced a decline of over 5% on its second day of trading, closing at HKD 37.94 with a transaction volume of HKD 117 million [1] - Guoen Technology officially listed on the Hong Kong Stock Exchange on February 4 and was included in the Hong Kong Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] Group 2 - According to the prospectus, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, holding a market share of 2.5% as of 2024 [1]

Core Viewpoint - Guoen Technology (02768) experienced a decline of over 5% on its second day of trading, closing at HKD 37.94 with a transaction volume of HKD 117 million [1] Group 1: Company Overview - Guoen Technology officially listed on the Hong Kong Stock Exchange on February 4 and was included in the Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] - Guoen Technology is engaged in the research, development, production, and sales of products for industrial and commercial use [1] Group 2: Market Position - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, holding a market share of 2.5% as of 2024 [1]

Group 1 - The core viewpoint of the article highlights the successful listing of Guoen Technology on the Hong Kong Stock Exchange, marking it as the first company in Shandong Province to achieve A+H dual listing in 2026, and the eighth H-share listed company in Qingdao [1][3] - On its first trading day, Guoen Technology's stock surged by 37.06%, reaching a market capitalization of HKD 14.864 billion, indicating a strong market performance [1] - The company specializes in the dual sectors of chemical new materials and health, focusing on upstream and downstream products such as gelatin and collagen [3] Group 2 - Guoen Technology raised approximately HKD 1 billion through the issuance of 30 million H-shares, with the funds earmarked for expanding production capacity in Thailand and domestically, establishing regional headquarters, and upgrading existing production bases [3] - The IPO received significant market recognition, with the public offering being oversubscribed by 2,251.85 times and the international placement by 10.03 times, making it one of the most highly subscribed new stocks recently [3] - The successful listing contributes to the growth of Qingdao's stock exchange, which now has 21 listed companies and has raised over HKD 13 billion through IPOs, with additional companies awaiting approval for listing [3]

Investment Rating - The report recommends subscription for the company, Guo'en Technology, with an IPO price range of HKD 34 to HKD 42 per share, suggesting a valuation of approximately 15 times the net profit for 2024 [3]. Core Insights - Guo'en Technology is a Chinese supplier focused on chemical new materials and gelatin, serving both the chemical and health industries. It ranks as the second-largest organic polymer modified materials and composite materials company in China by sales revenue, with a market share of 2.5% [2]. - The global polymer materials market is projected to grow from RMB 29.89 trillion in 2020 to RMB 45.61 trillion by 2024, with a compound annual growth rate (CAGR) of 11.1%. The Chinese polymer materials market is expected to expand from RMB 11.08 trillion in 2020 to RMB 16.28 trillion by 2024, with a CAGR of 10.1% [2]. - The company's revenue for 2022, 2023, and 2024 is forecasted to be RMB 13.41 billion, RMB 17.44 billion, and RMB 19.19 billion, respectively, reflecting a CAGR of 19.6%. Net profits for the same years are projected at RMB 663.11 million, RMB 465.89 million, and RMB 676.38 million [3]. Summary by Relevant Sections IPO Details - The IPO is set to raise HKD 10.577 billion, with a total offering of 30 million shares, of which 27 million shares are allocated for international placement and 3 million shares for public offering [1]. Market Position - Guo'en Technology is the second-largest producer of bone gelatin and the second-largest domestic brand producer of hollow capsules in China, indicating a strong market presence [2]. Financial Performance - The company is currently in a stable growth phase, with a significant safety margin in its valuation based on the IPO pricing compared to its A-share closing price [3].

Group 1: IPO Market Overview - In the past week (January 12-18, 2026), a total of 29 companies submitted IPO applications in the Hong Kong market, including Qian Dama, Yuanji Food, and others [5][6] - Three companies passed the hearing at the Hong Kong Stock Exchange: Guoen Co., Dongpeng Beverage, and Muyuan Foods, all of which are already listed on A-shares [5][10] - Only one company, Longqi Technology, initiated its IPO process, with a global offering of 52.2591 million shares at a maximum price of HKD 31 per share [5][13] Group 2: Companies Going Public - Four companies officially listed on the Hong Kong Stock Exchange: Haowei Group, BBSB International, Zhaoyi Innovation, and Hongxing Cold Chain [5][14] - Yuanji Food is the largest Chinese and global Chinese fast-food enterprise, with a revenue of RMB 1.982 billion, up 11.0% year-on-year, and a net profit of RMB 142 million, up 18.8% [8][9] - Estun, a leading industrial robot company, reported a revenue of RMB 3.804 billion, up 12.9% year-on-year, and a net profit of RMB 25.372 million, recovering from a loss in the previous year [10][11] Group 3: Company Highlights - Guoen Co. focuses on chemical new materials and reported a revenue of RMB 17.444 billion, up 10.0% year-on-year, with a net profit of RMB 713 million, up 40.2% [11] - Muyuan Foods, a leader in the pork industry, achieved a revenue of RMB 111.79 billion, up 15.5% year-on-year, and a net profit of RMB 15.112 billion, up 34.4% [12] - Longqi Technology is a global leader in smart products and services, with its IPO set to launch on January 14, 2026, and expected to list on January 22, 2026 [13][14]

Group 1: Market Activity - A total of 26 companies submitted applications to the Hong Kong Stock Exchange last week, marking a recent high in submissions [2] - Among the 26 companies, 3 passed the hearing, and 1 company is currently in the process of an IPO [10][12] Group 2: Industry Highlights - The semiconductor and computing sectors are particularly active, with companies like Weizhao Semiconductor and Placo Electronics submitting applications [2] - Weizhao Semiconductor reported a revenue of 615 million yuan and a profit of 40.25 million yuan for the first nine months of 2025 [2] - Placo Electronics achieved a revenue of 751 million yuan and a profit of 76.11 million yuan for the same period [2] Group 3: Robotics Sector - Several robotics companies, including Yifei Intelligent and Estun, are also pursuing listings [3] - Estun is ranked first in the industrial robotics sector by revenue, with a market share of 1.7% globally [3] - TuoStar is recognized as a leader in the domestic industrial robotics market, with a revenue of 1.688 billion yuan and a net profit of 47 million yuan for the first nine months of 2025 [3] Group 4: Biopharmaceutical Sector - Multiple biopharmaceutical companies are applying for listings, including Zeling Bio and Exegenesis Bio Inc. [4][5] - Zeling Bio reported a loss of 1.19 million yuan for the first nine months of 2025, while Exegenesis Bio has not yet received regulatory approval for its products [5][6] - Shanghai Shengsheng achieved a revenue of 538 million yuan and a net profit of 11.3 million yuan for the same period [4] Group 5: Food and Beverage Sector - The food and beverage sector is seeing significant activity, with companies like Yuanji Food and Qian Dama submitting applications [7] - Yuanji Food reported an adjusted net profit of 192 million yuan for the first nine months of 2025, a 31% increase year-on-year [7] - Qian Dama achieved a GMV of 14.8 billion yuan in 2024, maintaining its position as the top player in the community fresh product retail chain industry [7] Group 6: New Listings - Four new stocks were listed last week, with all experiencing price increases on their first trading day [13] - The stock of Howie Group, a global leader in CMOS image sensors, rose by 16.22% on its debut [13] - Zhaoyi Innovation, a storage chip leader, saw its stock price increase by 38.27% on its first day of trading [13]

Group 1 - The core viewpoint of the article is that Qingdao Guoen Technology Co., Ltd. has passed the listing hearing on the Hong Kong Stock Exchange, with China Merchants Securities International as the sole sponsor, focusing on new chemical materials and gelatin, collagen products [1] Group 2 - Guoen Technology serves the chemical and health industries, engaging in the R&D, production, and sales of products for industrial and commercial use [3] - The company has a diverse client base, including manufacturers in downstream industries such as automotive, new energy, and home appliances, as well as medical and pharmaceutical manufacturers in the health sector [3] - Guoen Technology is the second-largest company in China for organic polymer modified materials and organic polymer composite materials by sales revenue, holding a market share of 2.5% in 2024 [3] - The company is also the largest producer of polystyrene in China by production capacity in 2024 [3] Group 3 - Guoen Technology focuses on the natural collagen industry, with its subsidiary Dongbao Biological leveraging a vertical integration strategy to cover the entire value chain from collagen to end products [4] - The company is the second-largest producer of bone gelatin in China by production volume and the second-largest domestic brand in the hollow capsule industry by production volume in 2024 [5] Group 4 - The market size for organic polymer modified materials and organic polymer composite materials is projected to grow from RMB 303.8 billion in 2020 to RMB 544.8 billion in 2024, with a compound annual growth rate (CAGR) of 15.7% [5] - Guoen Technology's revenues for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 are approximately RMB 13.41 billion, RMB 17.44 billion, RMB 19.19 billion, and RMB 17.44 billion respectively [5][6] - The company's net profits for the same periods are approximately RMB 724 million, RMB 540 million, RMB 721 million, and RMB 721 million [5][6]